Incidence and molecular typing of Mycobacterium kansasii in a defined geographical area in Catalonia, Spain

M. SANTIN; F. ALCAIDE; M. A. BENITEZ; A. SALAZAR; C. ARDANUY; D. PODZAMCZER; G. RUFI; J. DORCA; R. MARTIN; F. GUDIOL

doi:10.1017/S095026880300150X

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

A retrospective population-based study was conducted between January 1990 and December 1998 to investigate the incidence of Mycobacterium kansasii disease and the heterogeneity of the isolates in a well-defined geographical area in Catalonia, Spain. A total of 136 patients were identified. Overall incidence and incidence in AIDS patients was 1·5 (95% CI 1·2–1·8) and 1089·6 (95% CI 689–1330) cases/100000 persons per year respectively, which is comparable to that reported from most of other geographical areas. Surprisingly, although 7 subtypes of M. kansasii have been consistently reported, in the present study 91 of the 93 isolates (97·8%) tested for genotype were subtype I, regardless of HIV status of the patients. In conclusion, the high rate of infection observed in the AIDS population contributes significantly to the burden of the M. kansasii disease in our area. M. kansasii disease in our geographical area was almost exclusively caused by subtype I regardless of HIV status.

Crossref Citations

This article has been cited by the following publications. This list is generated based on data provided by Crossref.

Alcaide, Fernando Calatayud, Laura Santín, Miguel and Martín, Rogelio 2004. Comparative In Vitro Activities of Linezolid, Telithromycin, Clarithromycin, Levofloxacin, Moxifloxacin, and Four Conventional Antimycobacterial Drugs against Mycobacterium kansasii . Antimicrobial Agents and Chemotherapy, Vol. 48, Issue. 12, p. 4562.

Shitrit, David Baum, Gerry L. Priess, Rachel Lavy, Anita Shitrit, Ariella Bar-Gil Raz, Meir Shlomi, Dekel Daniele, Bendayan and Kramer, Mordechai R. 2006. Pulmonary Mycobacterium kansasii Infection in Israel, 1999–2004. Chest, Vol. 129, Issue. 3, p. 771.

Field, Stephen K. and Cowie, Robert L. 2006. Lung Disease Due to the More Common Nontuberculous Mycobacteria. Chest, Vol. 129, Issue. 6, p. 1653.

Griffith, David E. Aksamit, Timothy Brown-Elliott, Barbara A. Catanzaro, Antonino Daley, Charles Gordin, Fred Holland, Steven M. Horsburgh, Robert Huitt, Gwen Iademarco, Michael F. Iseman, Michael Olivier, Kenneth Ruoss, Stephen von Reyn, C. Fordham Wallace, Richard J. and Winthrop, Kevin 2007. An Official ATS/IDSA Statement: Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial Diseases. American Journal of Respiratory and Critical Care Medicine, Vol. 175, Issue. 4, p. 367.

McGrath, E. E. McCabe, J. and Anderson, P. B. 2008. Guidelines on the diagnosis and treatment of pulmonary non-tuberculous mycobacteria infection. International Journal of Clinical Practice, Vol. 62, Issue. 12, p. 1947.

McGrath, Emmet E. and Anderson, Paul B. 2010. The therapeutic approach to non-tuberculous mycobacterial infection of the lung. Pulmonary Pharmacology & Therapeutics, Vol. 23, Issue. 5, p. 389.

Mitarai, Satoshi Kato, Seiya Ogata, Hideo Aono, Akio Chikamatsu, Kinuyo Mizuno, Kazue Toyota, Emiko Sejimo, Akiko Suzuki, Katsuhiro Yoshida, Shiomi Saito, Takefumi Moriya, Ataru Fujita, Akira Sato, Shuko Matsumoto, Tomoshige Ano, Hiromi Suetake, Toshinori Kondo, Yuji Kirikae, Teruo and Mori, Toru 2012. Comprehensive Multicenter Evaluation of a New Line Probe Assay Kit for Identification of Mycobacterium Species and Detection of Drug-Resistant Mycobacterium tuberculosis. Journal of Clinical Microbiology, Vol. 50, Issue. 3, p. 884.

Esteban, Jaime García-Pedrazuela, María Muñoz-Egea, María Carmen and Alcaide, Fernando 2012. Current treatment of nontuberculous mycobacteriosis: an update. Expert Opinion on Pharmacotherapy, Vol. 13, Issue. 7, p. 967.

Bakuła, Zofia Safianowska, Aleksandra Nowacka-Mazurek, Magdalena Bielecki, Jacek and Jagielski, Tomasz 2013. Short Communication: Subtyping ofMycobacterium kansasiiby PCR-Restriction Enzyme Analysis of thehsp65Gene. BioMed Research International, Vol. 2013, Issue. , p. 1.

2014. Exposure. p. 605.

Thomson, Rachel Tolson, Carla Huygens, Flavia and Hargreaves, Megan 2014. Strain variation amongst clinical and potable water isolates of M. kansasii using automated repetitive unit PCR. International Journal of Medical Microbiology, Vol. 304, Issue. 3-4, p. 484.

Kwenda, Geoffrey Churchyard, Gavin J. Thorrold, Catherine Heron, Ian Stevenson, Karen Duse, Adriano G. and Marais, Elsé 2015. Molecular characterisation of clinical and environmental isolates of Mycobacterium kansasii isolates from South African gold mines. Journal of Water and Health, Vol. 13, Issue. 1, p. 190.

Li, Yanming Pang, Yu Tong, Xunliang Zheng, Huiwen Zhao, Yanlin and Wang, Chen 2016. Mycobacterium kansasii Subtype I Is Associated With Clarithromycin Resistance in China. Frontiers in Microbiology, Vol. 7, Issue. ,

Yates, Victoria M. and Walker, Stephen L. 2016. Rook's Textbook of Dermatology, Ninth Edition. p. 1.

Machado, Edson Vasconcellos, Sidra Ezidio Gonçalves Cerdeira, Camillo Gomes, Lia Lima Junqueira, Ricardo Carvalho, Luciana Distasio de Ramos, Jesus Pais Redner, Paulo Campos, Carlos Eduardo Dias Caldas, Paulo Cesar de Souza Gomes, Ana Paula Chaves Sobral Goldenberg, Telma Montes, Fatima Fandinho Mello, Fernanda Carvalho de Queiroz Mussi, Vinicius de Oliveira Lasunskaia, Elena Soolingen, Dick van Miranda, Antonio Basílio de Rigouts, Leen Jong, Bouke C de Meehan, Conor J Catanho, Marcos and Suffys, Philip N 2018. Whole genome sequence of Mycobacterium kansasii isolates of the genotype 1 from Brazilian patients with pulmonary disease demonstrates considerable heterogeneity. Memórias do Instituto Oswaldo Cruz, Vol. 113, Issue. 9,

Bakuła, Zofia Brzostek, Anna Borówka, Paulina Żaczek, Anna Szulc-Kiełbik, Izabela Podpora, Agata Parniewski, Paweł Strapagiel, Dominik Dziadek, Jarosław Proboszcz, Małgorzata Bielecki, Jacek van Ingen, Jakko and Jagielski, Tomasz 2018. Molecular typing of Mycobacterium kansasii using pulsed-field gel electrophoresis and a newly designed variable-number tandem repeat analysis. Scientific Reports, Vol. 8, Issue. 1,

Bakuła, Zofia Kościuch, Justyna Safianowska, Aleksandra Proboszcz, Małgorzata Bielecki, Jacek van Ingen, Jakko Krenke, Rafał and Jagielski, Tomasz 2018. Clinical, radiological and molecular features of Mycobacterium kansasii pulmonary disease. Respiratory Medicine, Vol. 139, Issue. , p. 91.

Murugaiyan, Jayaseelan Lewin, Astrid Kamal, Elisabeth Bakuła, Zofia van Ingen, Jakko Ulmann, Vit Unzaga Barañano, Miren J. Humięcka, Joanna Safianowska, Aleksandra Roesler, Uwe H. and Jagielski, Tomasz 2018. MALDI Spectra Database for Rapid Discrimination and Subtyping of Mycobacterium kansasii. Frontiers in Microbiology, Vol. 9, Issue. ,

Turenne, Christine Y. 2019. Nontuberculous mycobacteria: Insights on taxonomy and evolution. Infection, Genetics and Evolution, Vol. 72, Issue. , p. 159.

Khosravi, Azar Dokht Asban, Bahareh Hashemzadeh, Mohammad and Nashibi, Roohangiz 2020. <p>Molecular Identification, and Characterization of <em>Mycobacterium kansasii</em> Strains Isolated from Four Tuberculosis Regional Reference Laboratories in Iran During 2016–2018</p>. Infection and Drug Resistance, Vol. Volume 13, Issue. , p. 2171.

Download full list

Article contents

Incidence and molecular typing of Mycobacterium kansasii in a defined geographical area in Catalonia, Spain

Abstract

Save article to Kindle

Save article to Dropbox

Save article to Google Drive

Reply to: Submit a response

Your details

You have entered the maximum number of contributors

Conflicting interests